Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants

References

• Gentile A, Bhutta Z, Bravo L, Samy AG, Garcia RD, Hoosen A, Islam T, Karimi A, Salem M, Simasathien S, et al. Pediatric disease burden and vaccination recommendations: understanding local differences. Int J Infect Dis 2010; 14:e649-58; PMID:20181506; http://dx.doi.org/10.1016/j.ijid.2009.11.006
   PubMed Web of Science ®Google Scholar
• Zhang L, Wilson DP. Trends in notifiable infectious diseases in China: implications for surveillance and population health policy. PLoS One 2012; 7:e31076; PMID:22359565; http://dx.doi.org/10.1371/journal.pone.0031076
   PubMed Web of Science ®Google Scholar
• Zhu F. Pertussis booster vaccine in China. Hum Vaccin 2011; 7:272-5; PMID:21307651; http://dx.doi.org/10.4161/hv.7.2.13861
   PubMed Web of Science ®Google Scholar
• Watt JP, Wolfson LJ, O'Brien KL, Henkle E, Deloria-Knoll M, McCall N, Lee E, Levine OS, Hajjeh R, Mulholland K, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009; 374:903-11; PMID:19748399; http://dx.doi.org/10.1016/S0140-6736(09)61203-4
   PubMed Web of Science ®Google Scholar
• World Health Organization. Polio vaccines: WHO position paper, January 2014–recommendations. Vaccine 2014; 32:4117-8; PMID:24768729; http://dx.doi.org/10.1016/j.vaccine.2014.04.023
   PubMed Web of Science ®Google Scholar
• World Health Organization. Certification of the Global Eradication of Poliomyelitis. Report of the fifth meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis, Geneva, 9 May 2000. Available at: http://polioeradication.org/wp-content/uploads/2016/07/6report.pdf (accessed on 21 October 2016)
   Google Scholar
• Liang X, Zhang Y, Xu W, Wen N, Zuo S, Lee LA, Yu J. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis 2006; 194:545-51; PMID:16897650; http://dx.doi.org/10.1086/506359
   PubMed Web of Science ®Google Scholar
• Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, Wang HQ, Wushouer F, Wang HB, Xu AQ, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med 2013; 369:1981-90; PMID:24256377; http://dx.doi.org/10.1056/NEJMoa1303368
   PubMed Web of Science ®Google Scholar
• Wang HB, Fang G, Yu WZ, Du F, Fan CX, Liu QL, Hao LX, Liu Y, Zheng JS, Qin ZY, et al. An outbreak of type pi vaccine-derived poliovirus in Sichuan province, China: emergence and circulation in an under-immunized population. PLoS One 2014; 9:e113880; PMID:25503964; http://dx.doi.org/10.1371/journal.pone.0113880
   PubMedGoogle Scholar
• Li R, Li CG, Li Y, Liu Y, Zhao H, Chen X, Kuriyakose S, Van Der Meeren O, Hardt K, Hezareh M, et al. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China. Vaccine 2016; 34:1436-43; PMID:26873055; http://dx.doi.org/10.1016/j.vaccine.2016.02.010
   PubMed Web of Science ®Google Scholar
• Li G, Zhang H, Zhou W, Ye Q, Li F, Wang H, Hou Q, Xu Y, Ma X, Tan Y, et al. Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization. Vaccine 2010; 28:4215-23; PMID:20399240; http://dx.doi.org/10.1016/j.vaccine.2010.03.061
   PubMed Web of Science ®Google Scholar
• Skibinski DA, Baudner BC, Singh M, O'Hagan DT. Combination vaccines. J Glob Infect Dis 2011; 3:63-72; PMID:21572611; http://dx.doi.org/10.4103/0974-777X.77298
   PubMedGoogle Scholar
• Public Health England. Use of Infanrix®-IPV+Hib in the infant schedule: Information for Healthcare Professionals. 2015. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/417203/Infanrix-IPV-Hib_information_for_healthcare_professionals_March_2015__3__CT.pdf [Accessed on 20 June 2016]
   Google Scholar
• Shao PL, Lu CY, Hsieh YC, Bock HL, Huang LM, Taiwan Infanrix-069 Study G. Immunogenicity and reactogenicity of DTPa-IPV/Hib vaccine co-administered with hepatitis B vaccine for primary and booster vaccination of Taiwanese infants. J Formos Med Assoc 2011; 110:415-22; PMID:21741011; http://dx.doi.org/10.1016/S0929-6646(11)60061-2
   PubMed Web of Science ®Google Scholar
• Anh DD, Van Der Meeren O, Karkada N, Assudani D, Yu TW, Han HH. Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: an open-label, phase III study. Hum Vaccin Immunother 2016; 12:655-7; PMID:26337197; http://dx.doi.org/10.1080/21645515.2015.1084451
   PubMed Web of Science ®Google Scholar
• Lin TY, Wang YH, Chang LY, Chiu CH, Huang YC, Tang H, Bock HL. Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age. Chang Gung Med J 2003; 26:315-22; PMID:12934847
   PubMedGoogle Scholar
• Phua KB, Quak SH, Lim FS, Goh P, Teoh YL, Datta SK, Han HH, Bock HL. Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus influenzae type b vaccine in a placebo-controlled rotavirus vaccine study. Ann Acad Med Singapore 2008; 37:546-53; PMID:18695765
   PubMed Web of Science ®Google Scholar
• Dagan R, Igbaria K, Piglansky L, Melamed R, Willems P, Grossi A, Kaufhold A. Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine. Pediatr Infect Dis J 1997; 16:1113-21; PMID:9427455; http://dx.doi.org/10.1097/00006454-199712000-00004
   PubMed Web of Science ®Google Scholar
• Halperin SA, King J, Law B, Mills E, Willems P. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Clin Infect Dis 1999; 28:995-1001; PMID:9427455; http://dx.doi.org/10.1086/514741
   PubMed Web of Science ®Google Scholar
• World Health Organization. Standard Procedure for Determining Immunity to Poliovirus using the Microneutralization Test (WHO/EPI/GEN 93.9) 1993. Available at: http://apps.who.int/iris/bitstream/10665/70486/1/WHO_EPI_GEN_93.9_eng.pdf [Accessed on 15 April 2016]
   Google Scholar